Issue 44, 2018

Enhancing anti-thrombogenicity of biodegradable polyurethanes through drug molecule incorporation

Abstract

Sufficient and sustained anti-thrombogenicity is essential for blood-contacting materials because blood coagulation and thrombosis caused by platelet adhesion and activation on material surfaces may lead to functional failure and even fatal outcomes. Covalently conjugating anti-thrombogenic moieties into a polymer, instead of surface modification or blending, can maintain the anti-thrombogenicity of the polymer at a high level over time. In this study, a series of randomly crosslinked, elastic, biodegradable polyurethanes (PU-DPA) were synthesized through a one-pot and one-step method from polycaprolactone (PCL) diol, hexamethylene diisocyanate (HDI) and an anti-thrombogenic drug, dipyridamole (DPA). The mechanical properties, hydrophilicity, in vitro degradation, and anti-thrombogenicity of the resultant PU-DPA polymers could be tuned by altering the incorporated DPA amount. The surface and bulk hydrophilicity of the polyurethanes decreased with increasing hydrophobic DPA amounts. All PU-DPA polymers exhibited strong mechanical properties and good elasticity. The degradation rates of PU-DPAs decreased with increasing DPA content in both PBS and lipase/PBS solutions. Covalently incorporating DPA into the polyurethane significantly reduced the platelet deposition compared to that of the polyurethane without DPA, and the polyurethane remained anti-thrombogenicity after degradation. The PU-DPA films also supported the growth of human umbilical vein endothelial cells. The attractive mechanical properties, blood compatibility, and cell compatibility of this anti-thrombogenic biodegradable polyurethane indicate that it has a great potential to be utilized for blood-contacting devices and cardiovascular tissue repair and regeneration.

Graphical abstract: Enhancing anti-thrombogenicity of biodegradable polyurethanes through drug molecule incorporation

Supplementary files

Article information

Article type
Paper
Submitted
16 Jūn. 2018
Accepted
07 Aug. 2018
First published
07 Aug. 2018

J. Mater. Chem. B, 2018,6, 7288-7297

Author version available

Enhancing anti-thrombogenicity of biodegradable polyurethanes through drug molecule incorporation

C. Xu, A. E. Kuriakose, D. Truong, P. Punnakitikashem, K. T. Nguyen and Y. Hong, J. Mater. Chem. B, 2018, 6, 7288 DOI: 10.1039/C8TB01582A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements